Phase II study of 852A administered subcutaneously in pa

Project: Research project

Project Details

Description

Phase II study of 852A administered subcutaneously in patients
StatusFinished
Effective start/end date4/13/06 → 6/30/14

Funding

  • COLEY PHARM GROUP
View all
View less